Drug Manufacturing and Formulation Contract II
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Maryland |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Set Aside: | Partial Small Business Set-Aside (FAR 19.5) |
| Posted Date: | Apr 24, 2025 |
| Due Date: | May 9, 2025 |
| Solicitation No: | NIHOD20250424WILLIAMETTI |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Sources Sought (Original)
- Original Published Date: Apr 24, 2025 04:22 pm EDT
- Original Response Date: May 09, 2025 05:00 pm EDT
- Inactive Policy: 15 days after response date
- Original Inactive Date: May 24, 2025
-
Initiative:
- None
- Original Set Aside: Partial Small Business Set-Aside (FAR 19.5)
- Product Service Code: 6850 - MISCELLANEOUS CHEMICAL SPECIALTIES
-
NAICS Code:
- 325 - Chemical Manufacturing
-
Place of Performance:
Rockville , MD 20852USA
Please take a moment to thoroughly review the attached Statement of Work (SOW), which outlines the full scope and details of the drug formulation and manufacturing contract requirement.
The goal of the contract is to complete all the manufacturing, documentation, formulation, fill and finish, packaging, and labeling required for investigational drug products. Throughout the period of performance (PoP) of the contract, the contractor must maintain the technical capabilities, minimum resources and organizational compliances with which to successfully conduct any awarded contract activity. The contractor must also maintain a good standing as a “Qualified Vendor” as determined by ORSC. Additionally, unless otherwise requested, any assigned research must be performed in compliance with all current FDA, World Health Organization (WHO), USP, ISO, and International Committee on Harmonization (ICH) policies, practices, procedures, guidelines and regulations specific to current good manufacturing practices (cGMP) as may be applicable.
- 6011 EXECUTIVE BLVD., SUITE 503L
- BETHESDA , MD 20892
- USA
- Dr. William H. M. Etti
- William.Etti@nih.gov
- Phone Number 3014024422
- Apr 24, 2025 04:22 pm EDTSources Sought (Original)
Related Document
| Apr 28, 2025 | [Sources Sought (Updated)] Drug Formulation and Manufacturing Contract II (DFMC) |
| May 5, 2025 | [Sources Sought (Updated)] Drug Formulation and Manufacturing Contract II (DFMC) |
See Also
Winter Abrasives and Road Salt Due Date: September 29, 2026 1:30pm Eastern Time
GARRETT COUNTY
Due by 9/29/2026
Supply & Delivery of Bulk Chemicals (Assorted) Open Supply & Delivery of Bulk
City of Baltimore
Due by 10/07/2026
Information Details Contact Commodities Number Number RFQ-000480 Title Title Polymeric Flocculant Type Type
City of Baltimore
Due by 1/07/2030
Bid Information Type Request for Quotation Status Issued Number Q-26-819 (Liquid Deicer for
Washington County
Due by 9/23/2026